novo glp 1 pill BREAKING: The FDA has approved the first oral GLP-1 for obesity, marking a major milestone in the weight-loss drug market and a potential inflection point for treatment access. The daily pill Scoring 2 Million Prescriptions, Novo's

The new pill joins drugmaker Novo Nordisk's oral Wegovy pill, which has spurred more than 600,000 prescriptions in the United States since it was approved in December

Current status: Phase 3 TRIUMPH clinical trials

BMI thresholds still exist because clinical trials primarily studied patients meeting specific BMI requirements, and FDA indications and insurance policies are generally based on those populations

It must be reconstituted with Bacteriostatic Water (BAC water) before use

Based on your health screening, your medication may include supportive supplements (like B6 or B12) , as selected by your prescriber

Another jogs